92 results
Page 3 of 5
424B5
3hzmw sd2h8pw
13 Nov 20
Prospectus supplement for primary offering
4:31pm
424B5
mtwna9 vp7wsf3
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
g7mbwom8 it
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B5
wpazb92 yku
3 Jun 20
Prospectus supplement for primary offering
8:33am
424B5
q5rdzcu
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
ddlqsb8 kvrc
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
rso5 7qkivnhihi
12 Mar 20
BioLineRx Reports Year-End 2019 Financial Results
7:00am
6-K
EX-99
m90koqx2 5nvdqvqo
13 Dec 19
BioLineRx Announces Updated Phase 2a Data from Triple
7:00am
6-K
EX-99
uj6dmvmlyknqyngtco9
5 Dec 19
BioLineRx Announces Preliminary Phase 2a Data from Triple
7:00am
6-K
EX-1
r468v67a7q6zmcdp37
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-3
uvc0wuv3cg vk
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
qhgcnjse
5 Nov 19
BioLineRx Announces BL-8040 in Combination with KEYTRUDA Shows Clinical Activity in Heavily Pretreated
9:00am
6-K
EX-99
h7bw i81xj9e
5 Nov 19
BioLineRx Presents Preclinical Data from Triple Combination
8:00am
6-K
EX-99
6gwqh
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
6jep xsv6j55fsb9b0j
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
vnfq0rf
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
ing75tny7m
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
EX-99
ds1mci0fbinxs3delw
11 Dec 18
BioLineRx Announces Initiation of Triple Combination Arm of
7:00am